Light Screening Composition Comprising A 1,3,5-Triazine Derivative, A Dibenzoylmethane Derivative And An Amino Substituted 2-Hydroxybenzophenone Derivative

Patent No. EP1323413 (titled "Light Screening Composition Comprising A 1,3,5-Triazine Derivative, A Dibenzoylmethane Derivative And An Amino Substituted 2-Hydroxybenzophenone Derivative") was filed by L'Oreal on Nov 14, 2002. The application was issued on Dec 21, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PLOUGMANN VINGTOFTSep 21, 2017PLOUGMANN VINGTOFT
STADA ARZNEIMITTELSep 19, 2017HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
BEIERSDORFSep 14, 2017-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1323413

L'OREAL
Application Number
EP02292839A
Filing Date
Nov 14, 2002
Status
Revoked
Feb 17, 2023
Publication Date
Dec 21, 2016